ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology

June 30, 1995

Bypass Budget For FY 1992 Shown In Chart

May 18, 1990

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

September 30, 2005